Temperature Sensitive Gene Therapy Protected by Cloud-Connected Smart Shipper and evo.is Cloud App for Real Time Distribution Visibility and Management
On November 5, 2018, BioLife’s JV partner SAVSU Technologies, a leading developer and supplier of precision cloud-connected thermal shipping containers and the most advanced cold chain visibility platform, announced that it is supplying its evo Smart Shipper and evo.is to AveXis, a gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases.
Bruce McCormick, SAVSU President, commented, “We are very pleased to partner with AveXis to supply our best in class evo Smart Shipper and evo.is cloud app. We look forward to additional announcements related to adoption of our innovative cold chain technologies by cell and gene therapy companies.”
Privately held SAVSU Technologies is driving improved cold chain management of time and temperature cell and gene therapies through innovation and leveraged relationships with the leading specialty couriers serving the regenerative medicine market. BioLife Solutions (NASDAQ:BLFS), the leading supplier of biopreservation tools for regenerative medicine, holds a 44% equity ownership position in SAVSU.
About SAVSU Technologies
SAVSU is a privately held designer and manufacturer of innovative high-performance cloud-connected passive storage and transport containers for temperature sensitive biologics and pharmaceuticals. Our mission is to improve global health by greatly reducing the waste and risks associated with the improper freezing and overheating of thermal-sensitive medicines and biologics. SAVSU has developed proprietary state-of-the-art technology to ultimately lower costs and improve delivery of these most essential materials. For more information please visit www.savsu.com.
To read the original press release, please click here.